Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

China controls a staggering portion of the United States’ pharmaceutical supply chain – and that means U.S. access to medicine can be weaponized.

The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...

President Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

Google’s policy update expands pharmaceutical advertising access in programmatic channels and shifts greater compliance risk ...

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to instability ...

Every pharmaceutical marketer wants their brand campaign to be more emotional, but do we know why emotional marketing is important for brand adoption? To help you answer this question, this article ...

Billions of prescriptions for generic drugs are filled in the U.S. annually. The FDA tests only a few dozen of them every ...

You see PET plastics every day, even if you do not notice them. They show up as drink bottles, food packaging, and synthetic ...

If Americans are getting squeezed by soaring prescription drug prices, veterans are getting crushed, writes Walter Woodring.